Shoreline Biosciences

From all of us at @ShorelineBio, we'd like to wish you a holiday season filled with health, joy and success!

@ShorelineBio will present at the 2024 Stifel Healthcare Conference, next week in New York. We invite you to attend our presentation to learn more about Shoreline’s approach to developing disease-modifying iNK cell therapies for autoimmune disorders. bit.ly/3YPNSoO

Meet Chad Viergever, our Sr. Manager of Corporate Development at @ShorelineBio. Originally from Sacramento, CA, Chad's journey led him to San Diego, where he found a love for the area and a passion for the life sciences. Join our team today: lnkd.in/gQC7unzw #CellTherapy

Meet Suping Peng, our dedicated senior scientist in our Natural Killer Cell group here at @ShorelineBio. Each member of our team is driven by a shared passion to develop groundbreaking products that will positively impact patients' lives. #EmployeeSpotlight

Meet Jen, our invaluable Sr. Scientist in our analytical dev group here at @ShorelineBio. Jen is dedicated to turning the brilliant ideas of our research team into life-saving cancer treatments, all while adding her unique touch of fun and charm to her work. #EmployeeSpotlight

The @ShorelineBio team would like to extend our sincere gratitude this holiday season for supporting our mission as we fight the war against cancer. May this holiday season give you many reasons to smile, and we wish you a happy, healthy, and prosperous New Year.

We are thrilled to announce Vanessa Jacoby's inclusion in the Top 50 Diverse Board Candidate list, a prestigious recognition by @equilarinc and the @Nasdaq Center for Board Excellence. Explore the full list of Top 50 Diverse Board Candidates here: lnkd.in/eEt4gQDx

From everyone at @Shorelinebio, we would like to #givethanks and wish everyone a happy Thanksgiving filled with gratitude and happiness. #CellTherapy #OncologyResearch #HappyThanksgiving

Meet David Murray, a member of our genome editing team at @ShorelineBio! Dave is a pioneer in CRISPR-based gene editing, focusing on knocking out genes that can hinder a cell's ability to target cancer & knocking in genes that can enhance that ability. lnkd.in/gQC7unzw

Our team is the foundation of what makes @ShorelineBio special & we are thrilled to introduce our Employee Spotlight Video Series. This series showcases a few of our brave & talented employees behind our next-gen iPSC-derived cell therapies. shorelinebio.com/join-us/ #Bloopers

@ShorelineBio is developing a novel approach to Macrophage cell therapy by utilizing the power of our induced pluripotent stem cells (iPSCs) technology. #iNK #Patients #Cancer #CellTherapy #OncologyResearch #Macrophages

@shorelinebio announced that it will participate in the 2023 Wedbush Pacgrow Healthcare Conference taking place August 8-9, 2023, in New York, NY. #iNK #Biotech #Cancer #CellTherapy #OncologyResearch

Our mission at @ShorelineBio is to create breakthrough medicines that change the lives of cancer patients everywhere. #CellTherapy #OncologyResearch #Cancer #WeAreHiring

Shoreline's intelligent engineering is revolutionizing the fight against cancer with next-gen induced Pluripotent Stem Cell (iPSC)-derived natural killer (iNK) cells and macrophages (iMACs). Curious to learn more? #iNK #Patients #Cancer #CellTherapy #OncologyResearch

Happy 4th of July from the @ShorelineBio team! Let's enjoy our freedoms and work together for a healthier and brighter tomorrow! #HappyFourth

At @ShorelineBio, we’re unlocking the power of cutting-edge gene editing with our advanced iPSC platform. If you’re passionate about advancing the future of cell therapies, check out our open positions and join our team! Join our team: lnkd.in/gQC7unzw

At @shorelinebio, we strive to create an industry-leading culture to maximize the potential of our diverse team. We're excited to welcome Steve Potter to our Executive team as we strive to win the war on cancer with our differentiated pipeline of immunotherapies. #CellTherapy

Join the fight against cancer at @Shorelinebio! We are looking for motivated professionals to join our team and develop innovative iPSC-derived natural killer cell and macrophage therapies. #CellTherapy #OncologyResearch #Cancer #JoinOurTeam

We are delighted to share the publication of data in Nature Biotechnology on the novel genome editing platform called #SLEEK, pioneered by our partner, @editasmed. @ShorelineBio has an exclusive license to the SLEEK technology for all iNK & iMACs for oncology indications.

Our mission at Shoreline Biosciences, Inc. is to create breakthrough medicines that change the lives of cancer patients everywhere. #CellTherapy #OncologyResearch #Cancer #WeAreHiring